Walmart, Costco, Amazon expected to dominate direct-to-consumer GLP-1 drugs

Walmart, Costco, and Amazon are expected to dominate the direct-to-consumer market for GLP-1 drugs. This shift is occurring because an increasing number of employers are dropping insurance coverage for these specific medications, including Wegovy and Zepbound. Consequently, more patients are being nudged toward seeking direct-to-consumer prescriptions to access these treatments. These retail giants are positioned to capture the resulting demand as traditional employer-sponsored healthcare coverage for GLP-1 drugs continues to decline significantly.